Table 1.

Results of glycocin precursor genes coexpression with palS and palT

Coexpressed genes	palA-his	sunA-his	hyp1-his	hyp2-his	enfA4-9-his	gccF-his
No coexpression (only precursor peptide)	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC
Coexpression with palS	+, Glc, NLC	+, Glc, NLC	+, Glc, NLC	NA, Glc, NLC	NA, NM, NLC	NA, NM, NLC
Coexpression with palT	NA, NM, leader cleaved	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC	NA, NM, NLC
Coexpression with palST	+, Glc, leader cleaved	+, Glc, NLC	+, Glc, NLC	NA, Glc, NLC	NA, NM, NLC	NA, NM, NLC

Glc refers to the peptide’s modification with a mass of +162; plus symbol refers to the presence of antibacterial activity of the purified peptide

NA no activity, NM no modifications, NLC no leader cleavage, palA-his pallidocin precursor, sunA-his sublancin precursor, hyp1-his putative glycocin precursor Hyp1, hyp2-his putative glycocin precursor Hyp2, enfA4-9-his enterocin F4-9 precursor, gccF-his glycocin F precursor